Legacy Edge Advisors LLC Invests $794,000 in iShares Biotechnology ETF $IBB

Legacy Edge Advisors LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,705 shares of the financial services provider’s stock, valued at approximately $794,000.

A number of other institutional investors and hedge funds have also modified their holdings of IBB. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the second quarter worth approximately $25,000. Cornerstone Planning Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth approximately $35,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth approximately $36,000. Parkside Financial Bank & Trust increased its position in shares of iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Finally, Close Asset Management Ltd increased its position in shares of iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.8%

Shares of IBB opened at $167.27 on Friday. iShares Biotechnology ETF has a one year low of $116.25 and a one year high of $179.64. The stock has a 50 day moving average price of $169.84 and a 200 day moving average price of $168.53.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.